This analysis revealed that the levels of CCL2, CCL3, CCL11, CCL22, CCL26 and CXCL10 were negatively associated with increased odds of FXS diagnosis, while the covariates age, BMI and time of sampling were not (Table 2). This evidence concerns the gene CCL3 and fragile X syndrome.